RAPS Approved Seminar on GMP and Regulatory Expectations for Early IND Products 2012 is dedicated to regulatory requirements that affect operations dealing with pharmaceutical products both in early and latter phases of development, including:
Vice Presidents of Technical Departments, Presidents, Directors, Managers, Quality, Regulatory Associates and Analysts, Research, Regulatory, Development Group Heads and any pharmaceutical worker who must deal with products both in early and latter phases of development.
